MARKET

VANI

VANI

Vivani Medical
NASDAQ
1.240
+0.010
+0.81%
Pre Market: 1.210 -0.03 -2.40% 05:47 09/28 EDT
OPEN
1.250
PREV CLOSE
1.230
HIGH
1.260
LOW
1.230
VOLUME
181
TURNOVER
0
52 WEEK HIGH
1.920
52 WEEK LOW
0.9228
MARKET CAP
111.85M
P/E (TTM)
-3.4550
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VANI last week (0914-0918)?
Weekly Report · 09/21 09:04
Vivani Medical Announces Merger Deal Involving Cortigent
TipRanks · 09/16 20:54
Weekly Report: what happened at VANI last week (0907-0911)?
Weekly Report · 09/14 09:04
Weekly Report: what happened at VANI last week (0831-0904)?
Weekly Report · 09/07 09:04
Weekly Report: what happened at VANI last week (0824-0828)?
Weekly Report · 08/31 09:04
Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?
NASDAQ · 08/29 23:35
Weekly Report: what happened at VANI last week (0817-0821)?
Weekly Report · 08/24 09:04
Analysts Offer Insights on Healthcare Companies: Vivani Medical (VANI) and InspireMD (NSPR)
TipRanks · 08/18 14:00
More
About VANI
Vivani Medical, Inc. is a clinical-stage biopharmaceutical company, developing miniature, ultra-long-acting drug implants. Leveraging its NanoPortal platform, it develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and to improve patient tolerance to their medication. Its segments include the Biopharm Division and Neurostimulation Division. Its pipeline includes NPM-139, NPM-133, NPM-115 and OKV-119. NPM-139 is a six-month, semaglutide implant under development for the treatment of chronic weight management. NPM-115 is an exenatide-based implant candidate also under development for the treatment of chronic weight management. NPM-119 refers to its six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of type 2 diabetes. These NanoPortal implants are designed for once or twice-yearly administration of medication.

Webull offers Vivani Medical Inc stock information, including NASDAQ: VANI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VANI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VANI stock methods without spending real money on the virtual paper trading platform.